Literature DB >> 9688527

Apolipoprotein A-I induced amyloidosis.

J Genschel1, R Haas, M J Pröpsting, H H Schmidt.   

Abstract

Amyloidosis is characterized by extracellular deposits of protein fibrils with a high content of beta-sheets in secondary structure. The protein forms together with proteoglycans amyloid fibrils causing organ damage and serious morbidity. Intact apolipoprotein A-I (apoA-I) is an important protein in lipid metabolism regulating the synthesis and catabolism of high density lipoproteins (HDL). Usually, apoA-I is not associated with amyloidosis. However, four naturally occurring mutant forms of apoA-I are known so far resulting in amyloidosis. The most important feature of all variants is the very similar formation of N-terminal fragments which were found in the amyloid deposits (residues 1-83 to 1-94). The new insights in the understanding of the association of apoA-I with HDL, its metabolism, and its hypothesized structural findings may explain a common mechanism for the genesis of apoA-I induced amyloidosis. Here we summarized the specific features of all known amyloidogenic variants of apoA-I and speculate about its metabolic pathway, which may have general implications for the metabolism of apoA-I.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9688527     DOI: 10.1016/s0014-5793(98)00668-1

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  11 in total

1.  Amyloid fibrils derived from the apolipoprotein A1 Leu174Ser variant contain elements of ordered helical structure.

Authors:  P Mangione; M Sunde; S Giorgetti; M Stoppini; G Esposito; L Gianelli; L Obici; L Asti; A Andreola; P Viglino; G Merlini; V Bellotti
Journal:  Protein Sci       Date:  2001-01       Impact factor: 6.725

2.  The "beta-clasp" model of apolipoprotein A-I--a lipid-free solution structure determined by electron paramagnetic resonance spectroscopy.

Authors:  Jens O Lagerstedt; Madhu S Budamagunta; Grace S Liu; Nicole C DeValle; John C Voss; Michael N Oda
Journal:  Biochim Biophys Acta       Date:  2012-01-08

3.  Dual role of an N-terminal amyloidogenic mutation in apolipoprotein A-I: destabilization of helix bundle and enhancement of fibril formation.

Authors:  Emi Adachi; Hiroyuki Nakajima; Chiharu Mizuguchi; Padmaja Dhanasekaran; Hiroyuki Kawashima; Kohjiro Nagao; Kenichi Akaji; Sissel Lund-Katz; Michael C Phillips; Hiroyuki Saito
Journal:  J Biol Chem       Date:  2012-12-11       Impact factor: 5.157

4.  Membrane effects of N-terminal fragment of apolipoprotein A-I: a fluorescent probe study.

Authors:  Valeriya Trusova; Galyna Gorbenko; Mykhailo Girych; Emi Adachi; Chiharu Mizuguchi; Rohit Sood; Paavo Kinnunen; Hiroyuki Saito
Journal:  J Fluoresc       Date:  2015-01-18       Impact factor: 2.217

Review 5.  Apolipoproteins and amyloid fibril formation in atherosclerosis.

Authors:  Chai Lean Teoh; Michael D W Griffin; Geoffrey J Howlett
Journal:  Protein Cell       Date:  2011-03-12       Impact factor: 14.870

6.  Interaction between the N- and C-terminal domains modulates the stability and lipid binding of apolipoprotein A-I.

Authors:  Mao Koyama; Masafumi Tanaka; Padmaja Dhanasekaran; Sissel Lund-Katz; Michael C Phillips; Hiroyuki Saito
Journal:  Biochemistry       Date:  2009-03-24       Impact factor: 3.162

7.  Mapping the structural transition in an amyloidogenic apolipoprotein A-I.

Authors:  Jens O Lagerstedt; Giorgio Cavigiolio; Linda M Roberts; Hyun-Seok Hong; Lee-Way Jin; Paul G Fitzgerald; Michael N Oda; John C Voss
Journal:  Biochemistry       Date:  2007-08-01       Impact factor: 3.162

8.  The new apolipoprotein A-I variant leu(174) --> Ser causes hereditary cardiac amyloidosis, and the amyloid fibrils are constituted by the 93-residue N-terminal polypeptide.

Authors:  L Obici; V Bellotti; P Mangione; M Stoppini; E Arbustini; L Verga; I Zorzoli; E Anesi; G Zanotti; C Campana; M Viganò; G Merlini
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

9.  Novel N-terminal mutation of human apolipoprotein A-I reduces self-association and impairs LCAT activation.

Authors:  Paul M M Weers; Arti B Patel; Leon C-P Wan; Emmanuel Guigard; Cyril M Kay; Anouar Hafiane; Ruth McPherson; Yves L Marcel; Robert S Kiss
Journal:  J Lipid Res       Date:  2010-09-30       Impact factor: 5.922

10.  Microenvironmentally controlled secondary structure motifs of apolipoprotein A-I derived peptides.

Authors:  Paola Mendoza-Espinosa; Danai Montalvan-Sorrosa; Victor García-González; Abel Moreno; Rolando Castillo; Jaime Mas-Oliva
Journal:  Mol Cell Biochem       Date:  2014-04-20       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.